Akcea Therapeutics Inc (AKCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 201,027 | 86,454 | 116,206 | 216,840 | 69,907 |
| Marketable Securities | 120,765 | 166,155 | 204,109 | 165,011 | 175,028 |
| Receivables | 10,269 | 4,597 | 636 | 3,295 | N/A |
| Inventories | N/A | 85 | N/A | N/A | N/A |
| Other current assets | 18,824 | 9,944 | 8,397 | 3,575 | 5,628 |
| TOTAL | $350,885 | $267,235 | $329,348 | $388,721 | $250,563 |
| Non-Current Assets | |||||
| PPE Net | 5,336 | 5,696 | 5,757 | 1,523 | 50 |
| Intangibles | 87,468 | 88,914 | 40,969 | 1,714 | 1,191 |
| Other Non-Current Assets | 15,028 | 3,416 | 3,054 | 3,047 | 661 |
| TOTAL | $107,832 | $98,026 | $49,780 | $6,284 | $1,902 |
| Total Assets | $458,717 | $365,261 | $379,128 | $395,005 | $252,465 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,153 | 30,969 | 26,959 | 29,843 | 30,315 |
| Accrued Expenses | 23,555 | 23,370 | 29,999 | 30,517 | 17,186 |
| Other current liabilities | 1,863 | 968 | 1,295 | 1,138 | 1,929 |
| TOTAL | $53,110 | $80,661 | $90,600 | $97,211 | $98,296 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 21,539 | 25,354 | 32,347 | 35,713 | 48,866 |
| Other Non-Current Liabilities | 15,018 | 4,442 | 0 | 0 | 0 |
| TOTAL | $16,743 | $7,876 | $7,117 | $7,390 | $7,869 |
| Total Liabilities | $69,853 | $88,537 | $97,717 | $104,601 | $106,165 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 92,770 | 89,433 | 89,211 | 85,718 | 85,593 |
| Common Shares | 93 | 89 | 87 | 86 | 67 |
| Retained earnings | -494,855 | -522,042 | -451,485 | -387,894 | -325,848 |
| Other shareholders' equity | -27 | -324 | -289 | -297 | -468 |
| TOTAL | $388,864 | $276,724 | $281,411 | $290,404 | $146,300 |
| Total Liabilities And Equity | $458,717 | $365,261 | $379,128 | $395,005 | $252,465 |